Planning

Denosumab Community Services

  • NHS South East London ICB

F01: Prior information notice (prior information only)

Notice identifier: 2025/S 000-019968

Procurement identifier (OCID): ocds-h6vhtk-050f76

Published 9 May 2025, 10:35am



Section one: Contracting authority

one.1) Name and addresses

NHS South East London ICB

160 Tooley Street

London

SE1 2TZ

Contact

Thomas Crouch

Email

thomas.crouch3@nhs.net

Country

United Kingdom

Region code

UKI - London

NHS Organisation Data Service

QKK

Internet address(es)

Main address

https://www.selondonics.org/icb/

one.3) Communication

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Denosumab Community Services

Reference number

PRJ2139

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

Notice for the Authorities (NHS South East London ICB) intent to follow the MSP PSR award route.

We are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.

Further details, including procurement timelines and engagement opportunities, will be communicated in due course.

Interested providers are encouraged to express their interest and stay informed about the process.

For enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ2139

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKI - London

two.2.4) Description of the procurement

The Community Denosumab Service is a GP led service covering the population and geography of Bromley borough. The service will operate a weekly clinic administering denosumab to patients who are referred via secondary care. The clinic is operated by a nurse / pharmacist with oversight by a GP. The service receives referrals from secondary care on a shared care basis and is required to be part of a shared care arrangement. The service includes both ambulatory and domiciliary patients.

The service aims to provide:

• Blood test appointments in a timely manner prior to injection

• Prescribing and administration of denosumab injection under a patient group direction (PGD)

• Follow up blood test, if necessary

The Service aims to achieve the following outcomes:

• Reduce pressure on secondary care and improve patient access to clinical services in the community

• Administer denosumab for the prevention of osteoporotic fractures

two.3) Estimated date of publication of contract notice

13 June 2025


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award